Genetic Disorder L.P. Kkr Sells 6,000,000 Shares of KKR & Co. Inc. (NYSE:KKR) Stock

KKR & Co. Inc. (NYSE:KKR) major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of KKR & Co. Inc. stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total value of $197,760,000.00. Following the completion of the transaction, the insider now owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. The trade was a 23.75 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

KKR & Co. Inc. Stock Performance

Shares of KKR & Co. Inc. stock traded down $0.74 during trading hours on Friday, hitting $115.39. 8,870,661 shares of the company’s stock traded hands, compared to its average volume of 5,209,330. The stock has a market capitalization of $102.49 billion, a price-to-earnings ratio of 34.65, a PEG ratio of 1.00 and a beta of 1.72. KKR & Co. Inc. has a 12-month low of $91.92 and a 12-month high of $170.40. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. The company has a fifty day simple moving average of $146.63 and a 200-day simple moving average of $141.89.

KKR & Co. Inc. Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were paid a dividend of $0.175 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $0.70 annualized dividend and a dividend yield of 0.61%. KKR & Co. Inc.’s payout ratio is currently 21.02%.

Hedge Funds Weigh In On KKR & Co. Inc.

Several institutional investors and hedge funds have recently bought and sold shares of the company. McIlrath & Eck LLC bought a new position in shares of KKR & Co. Inc. during the 4th quarter worth $26,000. Hanson & Doremus Investment Management bought a new stake in shares of KKR & Co. Inc. in the fourth quarter valued at approximately $27,000. Crews Bank & Trust purchased a new stake in shares of KKR & Co. Inc. during the 4th quarter valued at approximately $30,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of KKR & Co. Inc. during the 4th quarter valued at approximately $34,000. Finally, Cassady Schiller Wealth Management LLC purchased a new position in KKR & Co. Inc. in the 4th quarter valued at approximately $36,000. 76.26% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

KKR has been the topic of several analyst reports. Morgan Stanley reduced their price objective on shares of KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 6th. Hsbc Global Res downgraded KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 30th. Oppenheimer lifted their price objective on KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a research report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft lifted their target price on KKR & Co. Inc. from $158.00 to $159.00 and gave the stock a “buy” rating in a report on Monday, November 11th. Finally, Wells Fargo & Company cut their target price on shares of KKR & Co. Inc. from $151.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 5th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $161.43.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.